RAB8B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.773990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.394820E-01
Normal-vs-Stage2
2.703900E-02
Normal-vs-Stage3
1.477170E-01
Normal-vs-Stage4
3.651200E-01
Stage1-vs-Stage2
8.560800E-01
Stage1-vs-Stage3
6.984000E-01
Stage1-vs-Stage4
3.973600E-01
Stage2-vs-Stage3
5.808000E-01
Stage2-vs-Stage4
4.486200E-01
Stage3-vs-Stage4
2.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.541950E-02
Normal-vs-AfricanAmerican
4.734000E-01
Normal-vs-Asian
2.339400E-01
Caucasian-vs-AfricanAmerican
1.610210E-01
Caucasian-vs-Asian
2.245400E-01
AfricanAmerican-vs-Asian
1.802230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.760320E-02
Normal-vs-Female
2.803700E-02
Male-vs-Female
3.825600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.548400E-01
Normal-vs-Age(41-60Yrs)
8.430000E-02
Normal-vs-Age(61-80Yrs)
1.175530E-02
Normal-vs-Age(81-100Yrs)
2.277200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.320600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.995400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.907200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.561600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.014000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.092400E-02
Normal-vs-Daily Drinker
2.339800E-01
Normal-vs-Weekly Drinker
2.979700E-02
Normal-vs-Occasional Drinker
3.189700E-02
Normal-vs-Social Drinker
1.137760E-01
Non Drinker-vs-Daily Drinker
3.626800E-01
Non Drinker-vs-Weekly Drinker
8.986800E-01
Non Drinker-vs-Occasional Drinker
9.755000E-01
Non Drinker-vs-Social Drinker
7.794200E-01
Daily Drinker-vs-Weekly Drinker
4.919400E-01
Daily Drinker-vs-Occasional Drinker
3.811800E-01
Daily Drinker-vs-Social Drinker
3.878800E-01
Weekly Drinker-vs-Occasional Drinker
8.830600E-01
Weekly Drinker-vs-Social Drinker
7.424600E-01
Occasional Drinker-vs-Social Drinker
8.213400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.389400E-01
Normal-vs-Grade 2
1.630990E-01
Normal-vs-Grade 3
3.032000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.837960E-01
Grade 1-vs-Grade 3
6.327200E-01
Grade 1-vs-Grade 4
5.389400E-01
Grade 2-vs-Grade 3
2.026600E-01
Grade 2-vs-Grade 4
1.630990E-01
Grade 3-vs-Grade 4
3.032000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.156400E-02
Normal-vs-NonDiabetic
2.785600E-01
Diabetic-vs-NonDiabetic
8.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.311000E-01
Normal-vs-NoPancreatitis
1.239750E-02
Pancreatitis-vs-NoPancreatitis
9.320100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.260000E-02
Normal-vs-N1
2.397800E-02
N0-vs-N1
2.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.402200E-03
Normal-vs-TP53-NonMutant
4.198100E-02
TP53-Mutant-vs-TP53-NonMutant
3.734400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
